Company name
Anapa Biotech A/S
MeltPlex® multiplex PCR
What do we offer?
Multiplex PCR has become an increasingly popular method
to provide more, clinically relevant answers from the same
sample. We have developed MeltPlex - a homogenous
assay method to allow read-out of more than 20 answers
from a single PCR reaction. The method is applicable to
most PCR-based diagnostic platforms.
Solution
PCR readout is commonly limited to the current maximum
of 4-5 fluorophores on most instruments, where MeltPlex
allows detection of more than 20 targets. The method
enables higher-content diagnostic PCR panels for eg.
companion diagnostics, that addresses the majority of the
existing installed base of PCR instruments.
What differentiates us?
In many clinical settings, achieving multiplex answers from the same sample provide benefits both in terms of cost,
speed, added clinical value as well as preservation of limited samples. In cases such as sepsis, RSV-testing,
gastrointestinal testing and many others, a broad spectrum of agents are relevant for testing to assess possible
infections. Our differentiating parameter is the ability to separate over 20 targets in a single PCR tube.
What do we look for at the Medico Bazar?
We are looking for collaborators/test users of the MeltPlex technology as well as potential licensees in the
diagnostic field.
Contact data
Anapa Biotech A/S
Søren Morgenthaler Echwald, CEO
Dr. Neergaards Vej 3, 2970 Hørsholm
Phone: 25321773
sme@anapabitoech.com
www.anapabiotech.com